Different leukemia samples were tested, including acute myeloid leukemia (AML), APL ... Each individual aptamer was incubated alongside with monocyte-specific monoclonal antibodies anti-CD14 ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

Acute myeloid leukemia (AML) develops in the bone ... is a less common type of chronic leukemia that causes too many monocyte cells to build up in the blood. It often causes an enlarged spleen ...

Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly ...

The following is a summary of “Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in the February 2025 issue of the International Journal of ...

The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...

Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety ...

with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in patients ages 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome ...

Special tissues in these organs are important for the maturation of monocytes ... of blood cancer is generally considered to be acute myeloid leukemia (AML). AML has a survival rate of 31.7% ...